This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Biotechnology Ltd. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: The Innovations of Daniel J Lovell
Introduction
Daniel J Lovell is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of biotechnology, particularly in the treatment of rheumatoid arthritis. His work focuses on innovative methods that enhance the efficacy of TNF-α inhibitors.
Latest Patents
Daniel J Lovell holds a patent for "Methods for determining efficacy of TNF-α inhibitors for treatment of rheumatoid arthritis." This invention provides methods, uses, and compositions for treating rheumatoid arthritis. It describes the application of TNF-α inhibitors, such as human TNF-α antibodies, and outlines methods for determining their efficacy in treating the condition.
Career Highlights
Lovell is associated with AbbVie Biotechnology Ltd, where he continues to advance research in the field. His work has been instrumental in developing new therapeutic approaches for patients suffering from rheumatoid arthritis.
Collaborations
Some of his notable coworkers include Hartmut Kupper and Jeffrey Kent, who have collaborated with him on various projects within the biotechnology sector.
Conclusion
Daniel J Lovell's contributions to the field of biotechnology, particularly through his patent on TNF-α inhibitors, highlight his commitment to improving treatment options for rheumatoid arthritis. His work continues to impact the lives of many patients.